FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series A / Biotech startups that raised Series A in Massachusetts, United States

Biotech startups that raised Series A in Massachusetts, United States

Updated 16 Nov 2026

Reset
Biotech startups that raised Series A in Massachusetts, United States
One-time CSV
  • 223 funded companies, 191 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-a~massachusetts-united-states.csv223 rows × 18 columns
CompanyCityLast roundAmountDate
Arkea BioCharlestownSeries A$15.0M2026-09-29
Remedium BioNeedhamSeries A$10.0M2026-08-10
Dash BioBostonSeries A$30.0M2026-08-03
Xellar BiosystemsNewtonSeries A$29.5M2026-06-30
Stata DXCambridgeSeries A$400K2026-02-27
Third Arc BioBostonSeries A$52.0M2026-02-04
Prudentia SciencesCambridgeSeries A$20.0M2026-01-07
NeurableBostonSeries A$35.0M2025-12-19

8 rows of the CSV in 5 of its 18 columns.

223
Startups
$10.9B
Total raised
31
Funded in the last 12 months
$1.3B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

25 of 223
25 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Arkea Bio Arkea Bio develops technology that reduces greenhouse gas emissions from agriculture. Biotech Charlestown Series A $15.0M 2026-09-29 $60.5M Breakthrough Energy Ventures, Overview, Rabo Ventures 11 to 50 2021
Remedium Bio Remedium Bio develops gene therapy treatments for various diseases. Biotech Needham Series A $10.0M 2026-08-10 $13.8M National Science Foundation, MicroVentures, Longevitytech.fund +1 11 to 50 2020
Dash Bio Dash Bio develops automated laboratory workflows and software to support drug development through bioanalysis services. Artificial intelligence Boston Series A $30.0M 2026-08-03 $47.5M Freestyle Capital, Swift Ventures, LifeX Ventures +1 11 to 50 2024
Xellar Biosystems Xellar Biosystems analyzes drug testing and treatment data using artificial intelligence. Artificial intelligence Newton Series A $29.5M 2026-06-30 $93.2M Legend Capital, Tiantu Capital, Zhengxuan Investment +1 11 to 50 2022
Stata DX Stata DX develops eRapid disease management technology for implementing custom biomarker panels in clinical studies. Biotech Cambridge Series A $400K 2026-02-27 $3.6M MassVentures 1 to 10 2022
Third Arc Bio Third Arc Bio develops multifunctional antibodies for inflammatory and immunology diseases. Biotech Boston Series A $52.0M 2026-02-04 $217.0M T. Rowe Price, Cormorant Asset Management, Foresite Capital +1 11 to 50 2022
Prudentia Sciences Prudentia Sciences provides AI-powered asset diligence and valuation to reduce risk in drug development investment. Artificial intelligence Cambridge Series A $20.0M 2026-01-07 $27.0M Google Ventures, Iaso Ventures, Virtue 1 to 10 2023
Neurable Neurable develops AI tools for translating brain signals and brain-computer interface technology. Artificial intelligence Boston Series A $35.0M 2025-12-19 $57.3M National Science Foundation, Global Brain Corporation, Metaplanet +1 11 to 50 2015
AI Proteins AI Proteins designs and engineers miniprotein therapeutics using artificial intelligence. Artificial intelligence Boston Series A $42.5M 2025-11-19 $80.4M Intel Ignite, Lightchain Capital, Cobro Ventures 11 to 50 2021
Folia Health Folia Health is a platform that securely captures and shares users' health and symptom data. Biotech Boston Series A $10.5M 2025-10-01 $17.4M MassChallenge, Social Starts, Bantam Group +2 11 to 50 2016
Biobot Analytics Biobot Analytics offers a wastewater data platform that delivers population-level health insights. Artificial intelligence Cambridge Series A $13.4M 2025-06-06 $41.4M Y Combinator, Pioneer Fund, Soma Capital +2 11 to 50 2017
Progentos Therapeutics Progentos Therapeutics develops a multiple sclerosis treatment that stimulates the body's natural repair mechanisms. Biotech Watertown Series A $65.0M 2024-05-14 $65.0M Forbion Capital Partners, Dolby Family Ventures, Alta Partners +2 11 to 50 2023
Nabla Bio Nabla Bio uses an autoverse platform of biologically informed machine learning to co-develop antibody drugs. Artificial intelligence Cambridge Series A $26.0M 2024-05-14 $37.4M Y Combinator, Khosla Ventures, National Science Foundation +2 11 to 50 2020
Adaptilens Adaptilens develops an accommodating intraocular lens for cataract patients. Biotech Boston Series A $17.5M 2024-04-29 $19.1M MassChallenge, Pillar VC, Perceptive Advisors +2 1 to 10 2019
Corner Therapeutics Corner Therapeutics conducts biotechnology research focused on immunotherapy. Biotech Watertown Series A $58.5M 2024-04-18 $58.5M Bill & Melinda Gates Foundation, Ziff Capital Partners, Tanis ventures 11 to 50 2020
Edgewood Oncology Edgewood Oncology develops a first-in-class therapy for hard-to-treat cancers. Biotech Brookline Series A $20.0M 2024-03-25 $20.0M Alta Partners 1 to 10 2023
Tome Biosciences Tome Biosciences develops programmable gene insertion technology. Biotech Watertown Series A $213.0M 2023-12-12 $213.0M Andreessen Horowitz, Google Ventures, Polaris Partners +1 101 to 250 2021
Ascidian Therapeutics Ascidian Therapeutics is a biotechnology company focused on medical and clinical gene therapy. Biotech Boston Series A $40.0M 2023-11-08 $90.0M Apple Tree Partners 11 to 50 2020
i2o Therapeutics I2o Therapeutics is a biotech company that develops safe, effective oral formulations of therapies. Biotech Allston Series A $46.0M 2023-08-28 $90.4M Cerity Partners Ventures, Viva BioInnovator, Sanofi Ventures +1 11 to 50 2019
Luminopia Luminopia develops digital treatments for significant neuro-visual disorders. Biotech Cambridge Series A $16.0M 2023-06-27 $33.1M MassChallenge, U.S. Venture Partners, Bantam Group +2 11 to 50 2015
Sealonix Sealonix develops and commercializes hemostatic sealants made from proprietary biomaterials. Biotech Bedford Series A $20.0M 2023-05-12 $20.0M J2 Ventures, Excelestar Ventures, AMED Ventures +2 11 to 50 2023
Dyno Therapeutics Dyno Therapeutics uses artificial intelligence to develop gene therapies. Artificial intelligence Cambridge Series A $100.0M 2021-05-06 $109.0M Andreessen Horowitz, Google Ventures, CRV +2 101 to 250 2018
Orbita Orbita sells voice-first and conversational AI software that helps patients engage with digital healthcare. Artificial intelligence Boston Series A $9.0M 2020-05-27 $16.5M MassChallenge, nvp capital, Cultivation Capital +2 11 to 50 2015
Horsepower Technologies Horsepower Technologies develops orthotic devices for horses in animal healthcare. Biotech Lowell Series A $350K 2018-07-02 $9.4M Alumni Ventures, MassVentures, Green D Ventures +2 11 to 50 2008
Brontes Technologies Brontes Technologies develops dental imaging technology. Biotech Lexington Series A $7.0M 2004-05-05 $7.0M Flybridge 11 to 50 2003

Table 1. Biotech startups that raised Series A in Massachusetts, United States: the 25 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 223.

Largest rounds

Last 12 months
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 Third Arc Bio Third Arc Bio develops multifunctional antibodies for inflammatory and immunology diseases. Biotech Boston Series A $52.0M 2026-02-04 $217.0M T. Rowe Price, Cormorant Asset Management, Foresite Capital +1 11 to 50 2022
2 AI Proteins AI Proteins designs and engineers miniprotein therapeutics using artificial intelligence. Artificial intelligence Boston Series A $42.5M 2025-11-19 $80.4M Intel Ignite, Lightchain Capital, Cobro Ventures 11 to 50 2021
3 Neurable Neurable develops AI tools for translating brain signals and brain-computer interface technology. Artificial intelligence Boston Series A $35.0M 2025-12-19 $57.3M National Science Foundation, Global Brain Corporation, Metaplanet +1 11 to 50 2015
4 Dash Bio Dash Bio develops automated laboratory workflows and software to support drug development through bioanalysis services. Artificial intelligence Boston Series A $30.0M 2026-08-03 $47.5M Freestyle Capital, Swift Ventures, LifeX Ventures +1 11 to 50 2024
5 Xellar Biosystems Xellar Biosystems analyzes drug testing and treatment data using artificial intelligence. Artificial intelligence Newton Series A $29.5M 2026-06-30 $93.2M Legend Capital, Tiantu Capital, Zhengxuan Investment +1 11 to 50 2022
6 Prudentia Sciences Prudentia Sciences provides AI-powered asset diligence and valuation to reduce risk in drug development investment. Artificial intelligence Cambridge Series A $20.0M 2026-01-07 $27.0M Google Ventures, Iaso Ventures, Virtue 1 to 10 2023
7 Arkea Bio Arkea Bio develops technology that reduces greenhouse gas emissions from agriculture. Biotech Charlestown Series A $15.0M 2026-09-29 $60.5M Breakthrough Energy Ventures, Overview, Rabo Ventures 11 to 50 2021
8 Remedium Bio Remedium Bio develops gene therapy treatments for various diseases. Biotech Needham Series A $10.0M 2026-08-10 $13.8M National Science Foundation, MicroVentures, Longevitytech.fund +1 11 to 50 2020
9 Stata DX Stata DX develops eRapid disease management technology for implementing custom biomarker panels in clinical studies. Biotech Cambridge Series A $400K 2026-02-27 $3.6M MassVentures 1 to 10 2022

Table 2. Biotech startups that raised Series A in Massachusetts, United States: the 9 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 MassChallenge Startup accelerator Boston, United States 4 2%
2 Y Combinator Startup accelerator Mountain View, United States 4 2%
3 National Science Foundation Entrepreneurship program Alexandria, United States 3 1% 2 Remedium Bio, Neurable
4 Google Ventures Corporate venture arm San Francisco, United States 3 1% 1 Prudentia Sciences
5 MassVentures Venture capital firm Boston, United States 2 1% 1 Stata DX
6 Foresite Capital Private equity firm San Francisco, United States 2 1% 1 Third Arc Bio
7 Bantam Group Angel group Westwood, United States 2 1%
8 Soma Capital Venture capital firm San Francisco, United States 2 1%
9 Pillar VC Venture capital firm Boston, United States 2 1%
10 Apple Tree Partners Venture capital firm New York, United States 2 1%
11 Alta Partners Venture capital firm Jackson, United States 2 1%
12 Longwood Fund Venture capital firm Boston, United States 2 1%
13 Alumni Ventures Angel group Manchester, United States 2 1%
14 Alexandria Venture Investments Venture capital firm Pasadena, United States 2 1%
15 Polaris Partners Private equity firm Boston, United States 2 1%

Table 3. Biotech startups that raised Series A in Massachusetts, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 196 88% $10.1B
Software 32 14% $1.1B
Artificial intelligence 22 10% $773.2M
Hardware 7 3% $174.9M
Commerce 2 1% $20.6M
Education 1 0% $12.7M
Energy 1 0% $5.8M

Table 4. Biotech startups that raised Series A in Massachusetts, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series A 223 100% $26.0M

Table 5. Biotech startups that raised Series A in Massachusetts, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Cambridge 90 40%
Boston 57 26%
Watertown 8 4%
Lexington 7 3%
Woburn 6 3%
Natick 6 3%
Waltham 6 3%
Allston 4 2%
Newton 4 2%
Somerville 3 1%
Worcester 2 1%
Weston 2 1%

Table 6. Biotech startups that raised Series A in Massachusetts, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 1 3% $11.5M
October 2026 1 3% $30.0M
September 2026 5 16% $306.3M
August 2026 3 10% $70.0M
July 2026 1 3% $21.0M
June 2026 4 13% $93.1M
April 2026 3 10% $260.0M
March 2026 2 6% $61.0M
February 2026 2 6% $52.4M
January 2026 4 13% $137.5M
December 2025 3 10% $102.5M
November 2025 2 6% $132.5M

Table 7. Biotech startups that raised Series A in Massachusetts, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 26 12% $1.0B
2025 24 11% $1.3B
2024 19 9% $997.5M
2023 17 8% $1.1B
2022 22 10% $898.9M
2021 32 14% $1.1B

Table 8. Biotech startups that raised Series A in Massachusetts, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 19 9%
2020 to 2022 66 30%
2015 to 2019 78 35%
2010 to 2014 30 14%
Before 2010 28 13%

Table 9. Biotech startups that raised Series A in Massachusetts, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 72 32%
11 to 50 130 59%
51 to 100 8 4%
101 to 250 9 4%
251 to 500 2 1%
10,001 or more 1 0%

Table 10. Biotech startups that raised Series A in Massachusetts, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Massachusetts, United States whose last round is Series A are on the list?
223, in the file dated 16 November 2026. 31 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 223 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series A in Massachusetts, United States: 223 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in Massachusetts

Other sectors that raised Series A in Massachusetts

Cite: FundingWatcher, 223 biotech companies in Massachusetts, United States whose most recent round is Series A, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-a/massachusetts-united-states/